-
4
-
-
0034924032
-
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukemia
-
(2001)
Cancer Chemotherapy and Pharmacology
, vol.47
, pp. 15-21
-
-
Bellott, R.1
Auvrignon, A.2
Leblanc, T.3
Pérel, Y.4
Gandemer, V.5
Bertrand, Y.6
Méchinaud, F.7
Bellenger, P.8
Vernois, J.9
Leverger, G.10
Baruchel, A.11
Robert, J.12
-
6
-
-
0021934433
-
Estimate of the overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and complete remission
-
(1985)
Cancer Treatment Reports
, vol.69
, pp. 5-11
-
-
Brincker, H.1
-
9
-
-
0029068452
-
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia
-
(1995)
New England Journal of Medicine
, vol.332
, pp. 1678-1683
-
-
Dombert, H.1
Chastang, C.2
Fenaux, P.3
Reiffers, J.4
Bordessoule, D.5
Bouabdullah, R.6
Mandelli, F.7
Ferrant, A.8
Anzanneau, G.9
Tilly, H.10
Yver, A.11
Degos, L.12
-
13
-
-
0026603586
-
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
-
(1992)
Cancer Research
, vol.52
, pp. 891-896
-
-
Gabizon, A.A.1
-
14
-
-
0028920270
-
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 996-1003
-
-
Gill, P.S.1
Espina, B.M.2
Muggia, F.3
Cabriales, S.4
Tulpule, A.5
Esplin, J.A.6
Liebman, H.A.7
Forssen, E.8
Ross, M.E.9
Levine, A.M.10
-
15
-
-
9444258072
-
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Karposi's sarcoma
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 2353-2364
-
-
Gill, P.S.1
Wernz, J.2
Scadden, D.T.3
Cohen, P.4
Mukwaya, G.M.5
Von Roenn, J.H.6
Jacobs, M.7
Kempin, S.8
Silverberg, I.9
Gonzales, G.10
Rarick, M.U.11
Myers, A.M.12
Shepherd, F.13
Sawka, C.14
Pike, M.C.15
Ross, M.E.16
-
16
-
-
0032188805
-
The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
-
(1998)
Blood
, vol.92
, pp. 2322-2333
-
-
Grimwade, D.1
Walker, H.2
Oliver, F.3
Wheatley, K.4
Harrison, C.5
Harrison, G.6
Rees, J.7
Hann, I.8
Stevens, R.9
Burnett, A.10
Goldstone, A.11
-
17
-
-
0021130305
-
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly
-
(1984)
Journal of Clinical Oncology
, vol.2
, pp. 865-870
-
-
Kahn, S.B.1
Begg, C.B.2
Mazza, J.J.3
Bennett, J.M.4
Bonner, H.5
Glick, J.H.6
-
18
-
-
0031005627
-
Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study
-
(1997)
Blood
, vol.89
, pp. 3323-3329
-
-
Leith, C.P.1
Kopecky, K.J.2
Godwin, J.3
McConnell, T.4
Slovak, M.L.5
Chen, I.M.6
Head, D.R.7
Appelbaum, F.R.8
Willman, C.L.9
-
19
-
-
0027941369
-
Intensive postremission therapy in adults with acute myeloid leukemia
-
(1994)
New England Journal of Medicine
, vol.331
, pp. 896-903
-
-
Mayer, R.J.1
Davis, R.B.2
Schiffer, C.A.3
Berg, D.T.4
Powell, B.L.5
Schulman, P.6
Omura, G.A.7
Moore, J.O.8
McIntyre, O.R.9
Frei, E.10
-
20
-
-
0032816841
-
Liposome-encapsuled daunorubicin for PGP-related multidrug resistance
-
(1999)
British Journal of Haematology
, vol.106
, pp. 92-99
-
-
Michieli, M.1
Damiani, D.2
Ermacora, A.3
Masolini, P.4
Michelutti, A.5
Michelutti, T.6
Russo, D.7
Pea, F.8
Baccarini, M.9
-
24
-
-
0019812609
-
Treatment of acute myelocytic leukemia: A study by cancer and leukemia group B
-
(1981)
Blood
, vol.58
, pp. 1203-1212
-
-
Rai, K.R.1
Holland, J.F.2
Glidewell, O.J.3
Weinberg, V.4
Brunner, K.5
Obrecht, J.P.6
Preisler, H.D.7
Nawabi, I.W.8
Prager, D.9
Carey, R.W.10
Cooper, M.R.11
Haurani, F.12
Hutchison, J.L.13
Silver, R.T.14
Falkson, G.15
Wiernik, P.16
Hoagland, H.C.17
Bloomfield, C.D.18
James, G.W.19
Gottlieb, A.20
Ramanan, S.V.21
Blom, J.22
Nissen, N.I.23
Bank, A.24
Ellison, R.R.25
Kung, F.26
Henry, P.27
McIntyre, O.R.28
Kaan, S.K.29
more..
-
28
-
-
0029015209
-
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (<55-70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490)
-
(1995)
Blood
, vol.86
, pp. 457-462
-
-
Rowe, J.M.1
Andersen, J.W.2
Mazza, J.J.3
Bennett, J.M.4
Paietta, E.5
Hayes, F.A.6
Oette, D.7
Cassileth, P.A.8
Stadtmauer, E.A.9
Wiernik, P.H.10
-
30
-
-
0025196220
-
MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukemia
-
(1990)
British Journal of Haematology
, vol.75
, pp. 340-389
-
-
Sato, H.1
Preisler, H.2
Day, R.3
Raza, A.4
Larson, R.5
Brownman, G.6
Goldberg, J.7
Vogler, R.8
Grunwald, H.9
Gottlieb, A.10
Bennet, J.11
Gottesman, M.12
Pastan, I.13
-
31
-
-
0026634681
-
Modulation of multi-drug resistant multiple myeloma by cyclosporin
-
(1992)
Lancet
, vol.320
, pp. 255-259
-
-
Sonneveld, P.1
Durie, B.G.M.2
Lokhorst, H.M.3
Marie, J.P.4
Solbu, G.5
Suciu, S.6
Zittoun, R.7
Lowenberg, B.8
Nooter, K.9
-
32
-
-
0025611112
-
Antitumor activity of liposomal-encapsulated doxorubicin in advanced breast cancer: Phase II study
-
(1990)
Journal of the National Cancer Institute
, vol.82
, pp. 1706-1710
-
-
Treat, J.1
Greenspan, A.2
Forst, D.3
Sanchez, J.A.4
Ferrans, V.J.5
Potkul, L.A.6
Woolley, P.V.7
Rahman, A.8
-
33
-
-
0035008043
-
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma
-
(2001)
Annals of Oncology
, vol.12
, pp. 457-462
-
-
Tulpule, A.1
Rarick, M.U.2
Kolitz, J.3
Bernstein, J.4
Myers, A.5
Buchanan, L.A.6
Espina, B.M.7
Traynor, A.8
Letzer, J.9
Justice, G.R.10
McDonald, D.11
Roberts, L.12
Boswell, W.13
Nathwani, B.14
Levine, A.M.15
-
36
-
-
8944234342
-
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: A randomized trial by the European organization for research and treatment of cancer leukemia cooperative group
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 2150-2159
-
-
Zittoun, R.1
Suciu, S.2
Mandelli, F.3
De Witte, T.4
Thaler, J.5
Stryckmans, P.6
Hayat, M.7
Peetermans, M.8
Cadiou, M.9
Solbu, G.10
Petti, M.C.11
Willemze, R.12
|